0% found this document useful (0 votes)
19 views2 pages

Dr Reddy's Labs Valuation Analysis

The document presents a comparable company valuation for major players in the Indian pharmaceutical industry, detailing market data, financial metrics, and valuation ratios for each company. Key metrics include market capitalization, enterprise value, revenue, EBITDA, and P/E ratios for companies like Cipla, Sun Pharma, and Dr Reddy's Labs. The analysis also provides implied market values and share prices based on various valuation methods.

Uploaded by

sahilapk.222
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
19 views2 pages

Dr Reddy's Labs Valuation Analysis

The document presents a comparable company valuation for major players in the Indian pharmaceutical industry, detailing market data, financial metrics, and valuation ratios for each company. Key metrics include market capitalization, enterprise value, revenue, EBITDA, and P/E ratios for companies like Cipla, Sun Pharma, and Dr Reddy's Labs. The analysis also provides implied market values and share prices based on various valuation methods.

Uploaded by

sahilapk.222
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd

Comparable Company Valuation

Industry Data - Sector Related (Pharma Indian Industry)


Sr No. Name Market Cap CMP No of Share Debt Cash End EV Sales EBITDA NP
1 Cipla 96506.6 1195.35 80.74 960.89 1564.62 95902.87 24556.43 6956.53 3482.78
2 Sun [Link]. 286288.64 1193.2 239.93 1928.23 5770.29 282446.58 46304.89 14932.62 8554.4
3 Dr Reddy's Labs 94834.28 5685.5 16.68 1323 1730.2 94427.08 26765.6 8910.9 5091.2
4 Zydus Lifesci. 64543.21 637.65 101.22 191.9 573.1 64162.01 18776.1 5587.2 2926.2
5 Aurobindo Pharma 59437.65 1014.4 58.59 6648.63 6084.2 60002.08 26950.03 5883.17 2318.57
6 Lupin 56532.81 1241.75 45.53 3784.61 1293.13 59024.29 18604.92 3851.39 1348.69
7 Alkem Lab 54487.52 4557.15 11.96 1441.33 2616.89 53311.96 12351.4 2391.29 1430.34
8 Syngene Intl. 30350.11 754.95 40.2 833 531.7 30651.41 3498.5 1408 498.3
9 Biocon 28094.06 234 120.06 18252.3 2400.1 43946.26 13599.9 4356.6 715.4
10 Ipca Labs. 27840.22 1097.35 25.37 1987.46 1853.24 27974.44 6676.8 1321.51 488.45
Amount in crores.
Comparable Company Valuation
Market Data Financial Valuation
Comp. Ticker Share Price Share Outstanding Equity Value Net Debt E.V Revenue EBITDA Net Income EV/Revenue EV/EBITDA P/E
Cipla 1,195.35 80.74 96,512.56 -603.73 95,908.83 24,556.43 6,956.53 3,482.78 3.91x 13.79x 27.71x
Sun [Link]. 1,193.20 239.93 286,284.48 -3,842.06 282,442.42 46,304.89 14,932.62 8,554.40 6.10x 18.91x 33.47x
Dr Reddy's Labs 5,685.50 16.68 94,834.14 -407.20 94,426.94 26,765.60 8,910.90 5,091.20 3.53x 10.60x 18.63x
Zydus Lifesci. 637.65 101.22 64,542.93 -381.20 64,161.73 18,776.10 5,587.20 2,926.20 3.42x 11.48x 22.06x
Aurobindo Pharma 1,014.40 58.59 59,433.70 564.43 59,998.13 26,950.03 5,883.17 2,318.57 2.23x 10.20x 25.63x
Lupin 1,241.75 45.53 56,536.88 2,491.48 59,028.36 18,604.92 3,851.39 1,348.69 3.17x 15.33x 41.92x
Alkem Lab 4,557.15 11.96 54,503.51 -1,175.56 53,327.95 12,351.40 2,391.29 1,430.34 4.32x 22.30x 38.11x
Syngene Intl. 754.95 40.20 30,348.99 301.30 30,650.29 3,498.50 1,408.00 498.30 8.76x 21.77x 60.91x
Biocon 234.00 120.06 28,094.04 15,852.20 43,946.24 13,599.90 4,356.60 715.40 3.23x 10.09x 39.27x
Ipca Labs. 1,097.35 25.37 27,839.77 134.22 27,973.99 6,676.80 1,321.51 488.45 4.19x 21.17x 57.00x

High 8.76x 22.30x 60.91x


th
75 Percentile 4.29x 20.60x 41.26x
Average 4.28x 15.56x 36.47x
Median 3.72x 14.56x 35.79x
25th Percentile 3.28x 10.82x 26.15x
Low 2.23x 10.09x 18.63x

Cipla Comparable Valuation EV/Revenue EV/EBITDA P/E


Implied Enterprise Value 91,271.0 101,264.1 124,030.4
Net Debt -603.7 -603.7 -603.7
Implied Market Value 91,874.7 101,867.8 124,634.1
Share Outstanding 80.7 80.7 80.7
Implied Value Per Share 1,137.9 1,261.7 1,543.6
Source: The Valuation School, [Link]
OverValued UnderValued UnderValued

You might also like